Mandatory notification of trade
(Lysaker, Norway, 3 October 2006) Today, Bernt-Olav Røttingsnes, CFO in Navamedic, has acquired a total of 44.000 shares in Navamedic ASA.The 44.000 shares were purchased at an average price of NOK 20,48 per share. Mr. Bernt-Olav Røttingsnes has a new holding in Navamedic after the purchase of 50.000 shares.For further information, please contact:Bernt-Olav Røttingsnes, CFO/IROE-mail: bor@navamedic.comOffice: +47 67 11 25 44Mobile: +47 913 47 021About Navamedic ASA:Navamedic is a Norwegian speciality pharmaceutical company focusing on the development and production of